CBP-501 acetate

• Target :

  MAPK|||MAP3K|||CaMK|||Chk|||Calmodulin

• Related Pathways :

  Cell Cycle/Checkpoint|||Neuroscience|||MAPK|||Membrane transporter/Ion channel

• Bioactivity :

  CBP-501 acetate is a cell-permeable calmodulin-binding peptide and a candidate G2 phase checkpoint abrogator. It inhibits several Ser216-specific kinases, including MAPKAP-K2, C-Tak1, CHK1, and CHK2, with IC50 values of 0.9 ?M, 1.4 ?M, 3.4 ?M, and 6.5 ?M, respectively. CBP-501 acetate is applicable to various cancer research studies.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C